Selinexor (Xpovio™) is a nuclear export inhibitor used in the treatment of multiple myeloma.

Trastuzumab-anns (Kanjinti™) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Bevacizumab-bvzr (Zirabev®) is a biologic therapy that works by slowing down or stopping blood supply to cancer cells, thereby slowing their growth.

Filgrastim-aafi (Nivestym™) is a colony stimulating factor biosimilar that is used to promote the production and function of blood cells.